Menarini Group, a leading Italian pharmaceutical company with a global presence, has chosen to partner with Hypatia Marketing & Digital Research for the creation and management of a challenging qualitative and quantitative investigation project on the domestic market.
The choice fell on Hypatia thanks to the proposal of innovative methodologies presented, which enabled us to offer a new research design. Management of the research was carried out by experts in the pharmaceutical and medical industries in order to ensure a strong continuity link between innovation and control.
Satisfaction for this new joint venture within the Roncaglia Group was expressed by the words of the Chairman, Armando Roncaglia: "A valuable acquisition in the pharmaceutics sector for Hypatia that consolidates its presence in the research market next to multinational giants. We are all very happy with the way this start-up is performing in the market. In fact, it is chosen by large enterprises, as demonstrated by our portfolio, thanks to its dynamic management and deep knowledge of traditional and innovative methods, integrated ad hoc on the customer's goal ".